Weight Loss Peptidomimetic Adipotide Powder Ftpp Peptide

Product Details
Customization: Available
Powder: Yes
Customized: Customized
Still deciding? Get samples of US$ 120/box
Request Sample
Diamond Member Since 2019

Suppliers with verified business licenses

Audited Supplier

Audited by an independent third-party inspection agency

to see all verified strength labels (11)
  • Weight Loss Peptidomimetic Adipotide Powder Ftpp Peptide
  • Weight Loss Peptidomimetic Adipotide Powder Ftpp Peptide
  • Weight Loss Peptidomimetic Adipotide Powder Ftpp Peptide
Find Similar Products

Basic Info.

Model NO.
top quality
Suitable for
Elderly, Children, Adult
State
Solid
Purity
>99%
Transport Package
10 Vials Per Box
Specification
2mg/vial
Trademark
senwayer
Origin
China
HS Code
2601111000
Production Capacity
4000 Boxes Per Month

Product Description

Weight Loss Peptidomimetic Adipotide Powder FTPP peptide
Weight Loss Peptidomimetic Adipotide Powder Ftpp Peptide

 

Product description

Product name Adipotide
CAS No. N/A
Molecular Formula C62H98N16O22
Molecular weight 1419.53552
Grade Standard Medicine Grade
COA Avaliable
Specification 2mg/vial

Physical Characters and specifications

Item Specifications
Appearance White powder.
Purity 99%min
Boiling point 1802.9±65.0ºC at 760 mmHg
Density 1.4±0.1 g/cm3
Refractive index 1.576
Flash point 1044.2±34.3ºC
Storage condition 2-8ºC
Shelf life 2 years
 

Product Introduction

Adipotide is a new drug that is showing some promise in the area of obesity research. This drug was initially created as a cancer treatment designed to starve cancer cells of a blood supply so they would stop growing. The effects of Adipotide have shown that the drug actually starves fat cells of blood forcing them to die and be reabsorbed into the body. Initial tests were done on rats and then moved on to monkeys. The results from testing on rats showed a 30 percent decrease in body weight. After four weeks of daily injections of Adipotide followed by four weeks of non-treatment, 10 obese female rhesus monkeys lost an average of 11 percent of their body weight and 39 percent of fat deposits. Most of the loss was experienced during the non-treatment period.
 

Function

Adipotide, a peptidomimetic with sequence CKGGRAKDC-GG-D(KLAKLAK)2, is an experimental proapoptotic drug that has been shown to cause rapid weight loss in mice and rhesus monkeys. Its mechanism of action is to target specific blood vessels supplying adipose tissue with blood, cause the vessels to shrink and the fat cells fed by those vessels to undergo apoptosis.Adipotide is designed to bind to two receptors, ANXA2 and prohibitin, that are specific to blood vessels supplying white adipose tissue.



Weight Loss Peptidomimetic Adipotide Powder Ftpp Peptide
Weight Loss Peptidomimetic Adipotide Powder Ftpp Peptide
Weight Loss Peptidomimetic Adipotide Powder Ftpp Peptide
Weight Loss Peptidomimetic Adipotide Powder Ftpp Peptide

Weight Loss Peptidomimetic Adipotide Powder Ftpp Peptide
Weight Loss Peptidomimetic Adipotide Powder Ftpp Peptide
Weight Loss Peptidomimetic Adipotide Powder Ftpp Peptide

 

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now
Contact Supplier